Inotiv, Inc. Announces Quarter Results and Conference Call
Inotiv, Inc. (NASDAQ: NOTV) is making headlines as it prepares to reveal its financial outcomes for the fiscal year 2025, specifically for the fourth quarter ending September 30, 2025. This significant announcement comes just ahead of a scheduled conference call that will take place on December 3, 2025, at 4:30 p.m. Eastern Time. During this call, the company's leadership will engage with participants, discussing the previous quarter's performance and addressing insights into future endeavors.
Join the Conference Call
For those interested in participating in this important event, the conference call can be accessed by dialing:
Domestic Callers
1-800-225-9448
International Callers
1-203-518-9708
To join, mention the conference ID associated with Inotiv.
Webcast Access
The conference call will also be available via a live webcast, providing an accessible platform for investors and interested parties. This webcast can be found in the Investors segment of Inotiv's website. A link to directly access the stream will also be provided on their site, ensuring a smooth experience for attendees seeking to follow along in real-time.
Replay Availability
For those unable to tune into the live broadcast, Inotiv will offer a replay of the conference call, which will be accessible shortly after the event concludes. This feature is an excellent way for stakeholders to stay informed on the latest financial developments and corporate news.
About Inotiv, Inc.
Inotiv is a prominent contract research organization dedicated to delivering comprehensive solutions related to nonclinical and analytical drug discovery and development. The company's expertise encompasses research models alongside a suite of products and services that assist in the streamlined development of new drugs and medical devices. By focusing on efficiency, data improvement, and cost reductions, Inotiv aims to facilitate the progressive journey of new therapeutic products from the discovery phase through to market introduction.
The company prides itself on supporting research objectives while promoting collaboration to nurture a healthier and safer world. More insights about its extensive offerings and recent updates can be found on Inotiv's corporate website, reflecting its commitment to innovation in the life sciences field.
Company Contact Information
If you have specific inquiries or need further information, please reach out through the following contacts:
Inotiv, Inc.
Beth A. Taylor, Chief Financial Officer
Phone: (765) 497-8381
Email: beth.taylor@inotiv.com
Investor Relations
LifeSci Advisors
Steve Halper
Phone: (646) 876-6455
Email: shalper@lifesciadvisors.com
Frequently Asked Questions
What is the date of the upcoming conference call?
The conference call is scheduled for December 3, 2025 at 4:30 p.m. Eastern Time.
How can I participate in the conference call?
You can join the call by dialing 1-800-225-9448 for domestic callers or 1-203-518-9708 for international callers.
Is there a webcast available for the conference call?
Yes, the call will be streamed live on Inotiv’s Investors website.
Will there be a replay of the call?
Yes, a replay will be available shortly after the call concludes for those who cannot listen live.
What services does Inotiv, Inc. provide?
Inotiv is a contract research organization offering services in drug discovery, development, and related products to enhance efficiency in bringing new therapies to market.